HIMS
Hims Hers Health Inc
NYSE: HIMS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$26.33
-5.66% today
Updated 2026-04-29
Market cap
$6.08B
P/E ratio
51.63
P/S ratio
2.59x
EPS (TTM)
$0.51
Dividend yield
—
52W range
$14 – $70
Volume
38.8M
Hims Hers Health Inc (HIMS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
5.47%
Operating margin
2.72%
ROE
25.20%
ROA
5.29%
Debt/equity
2.34x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $26.68M | $-75.24M | 29.25% | -284.00% | -282.03% |
| 2019 | $82.56M | $-72.06M | 54.03% | -90.14% | -87.29% |
| 2020 | $148.76M | $-18.11M | 73.58% | -10.18% | -12.18% |
| 2021 | $271.88M | $-107.66M | 75.22% | -42.31% | -39.60% |
| 2022 | $526.92M | $-65.68M | 77.57% | -13.04% | -12.46% |
| 2023 | $872.00M | $-23.55M | 81.99% | -3.38% | -2.70% |
| 2024 | $1.48B | $126.04M | 79.45% | 4.19% | 8.54% |
| 2025 | $2.35B | $128.37M | 73.84% | 4.50% | 5.47% |